Scios Nova Inc. preclinical data

Researchers presented animal results on the potential utility of basic fibroblast growth factor (bFGF) in decreasing brain injury.

As reported at the Joint Conference on Stroke and Cerebral Circulation in San Antonio, cats were treated iv with either placebo, or 5, 50 or 250 µg/kg/hour of bFGF between hours one and four of middle cerebral artery occlusion. ...